...
首页> 外文期刊>Frontiers in Pharmacology >Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
【24h】

Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria

机译:射香宝心丸通过靶向线粒体纠正大鼠代谢综合征模型的代谢紊乱

获取原文

摘要

Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action. Methods: A diet-induced rat model of MS was established according to accepted methods, and the rats were randomly divided into two groups: a control group (0.9% NaCl, 100 mg/kg~(?)d) and a SBP-treated group (SBP, 100 mg/kg~(?)d). Systolic blood pressures, fasting blood glucose (FBS) levels, triglyceride (TG) levels, high-density lipoprotein cholesterol (HDL-C) levels, body weights, and abdominal perimeters were dynamically monitored and analyzed. Serum leptin, adiponectin, TNF-α, IL-6, and IL-10 levels were measured by ELISA. Leptin, adiponectin, TNF-α, IL-6, and IL-10 expression in adipose tissue, as well as AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) expression in heart, liver, skeletal muscle, and adipose tissue was measured by western blot. Expression of the mitochondrial protein UCP2, Cytochrome b and ATPase was observed by immunofluorescent staining. Results: SBP significantly decreased serum TG, TC, LDL-C levels and increased HDL-C levels. SBP also optimized the leptin/adiponectin ratio by decreasing leptin expression and increasing adiponectin expression in adipose tissue. SBP antagonized inflammatory reactions by promoting IL-10 expression in adipose tissue while inhibiting TNF-α and IL-6 expression. SBP improved lipid metabolism by up-regulating the expression of AMPK and PGC-1α. Furthermore, SBP decreased the severity of MS and its complications by adjusting the expression of several mitochondrial proteins, including UCP2, Cytochrome b and ATPase. Conclusion: SBP exhibits prominent therapeutic effects in the setting of MS. Possible mechanisms of action may be related to its anti-inflammatory and anti-oxidative characteristics, as well as its effects on improving lipid metabolism and protecting mitochondrial function.
机译:背景:代谢综合症(MS)是一种全球流行病,对社会经济和公共健康都有重大影响。这项研究报告了观察性射囊保心丸(SBP)在MS大鼠模型中的作用,并探讨了其潜在的作用机制。方法:按照公认的方法建立饮食诱导的MS大鼠模型,将大鼠随机分为两组:对照组(0.9%NaCl,100 mg / kg〜(d)d)和SBP治疗。组(SBP,100 mg / kg〜(?)d)。动态监测和分析收缩压,空腹血糖(FBS)水平,甘油三酸酯(TG)水平,高密度脂蛋白胆固醇(HDL-C)水平,体重和腹围。通过ELISA测量血清瘦素,脂联素,TNF-α,IL-6和IL-10水平。脂肪组织中的瘦素,脂联素,TNF-α,IL-6和IL-10的表达,以及AMP激活的蛋白激酶(AMPK)和过氧化物酶体增殖物激活的受体γ共激活因子1-α(PGC-1α)的表达通过蛋白质印迹法测量心脏,肝脏,骨骼肌和脂肪组织。通过免疫荧光染色观察到线粒体蛋白UCP2,细胞色素b和ATP酶的表达。结果:SBP显着降低了血清TG,TC,LDL-C水平和HDL-C水平。 SBP还通过降低脂肪组织中的瘦素表达和增加脂联素表达来优化瘦素/脂联素的比例。 SBP通过促进脂肪组织中IL-10的表达同时抑制TNF-α和IL-6的表达来拮抗炎症反应。 SBP通过上调AMPK和PGC-1α的表达来改善脂质代谢。此外,SBP通过调节几种线粒体蛋白(包括UCP2,细胞色素b和ATPase)的表达来降低MS的严重程度及其并发症。结论:SBP在MS环境中具有突出的治疗作用。可能的作用机制可能与其抗炎和抗氧化特性有关,以及对改善脂质代谢和保护线粒体功能的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号